Purpose: To report two cases of idiopathic intraocular cilia presenting as sectoral scleritis with progressive intraocular inflammation.

Methods: Both patients were treated with intravitreal antibiotics and underwent pars plana vitrectomy where the cilia were removed and identified on histopathology.

Results: One patient developed a retinal detachment while being treated for presumed endophthalmitis. The intraocular cilium was discovered during pars plana vitrectomy. In the second case, the cilium was detected on dilated fundus exam and was believed to be the cause of the patient's scleritis and vitritis. Therapeutic vitrectomy was performed. In both cases, the cilia were positively identified on histopathology.

Conclusion: Idiopathic intraocular penetration of cilia should be considered in the differential diagnosis of sectoral scleritis with progressive intraocular inflammation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213081PMC
http://dx.doi.org/10.1097/ICB.0000000000001006DOI Listing

Publication Analysis

Top Keywords

sectoral scleritis
12
scleritis progressive
12
progressive intraocular
12
penetration cilia
8
presenting sectoral
8
intraocular inflammation
8
idiopathic intraocular
8
pars plana
8
plana vitrectomy
8
intraocular
6

Similar Publications

Rhegmatogenous retinal detachment (RRD) is an ocular emergency as it is sight-threatening and requires urgent surgical intervention. Ulcerative colitis (UC) is an immune-mediated inflammatory bowel disease that can present with ocular manifestations. The objective of this case report is to share the rare presentation of RRD associated with UC leading to diagnosis and management dilemmas.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to describe nodular histiocytic iritis in dogs, focusing on its clinical presentation, histopathology, management, and outcomes.
  • Researchers reviewed the records of five dogs (four Border Collies and one crossbreed, aged 1.5-3.4 years) diagnosed with this condition through histopathology.
  • Findings revealed unilateral iris thickening resembling neoplasia but related to inflammation; enucleation or biopsies were performed, with successful outcomes and no recurrence observed in follow-ups.
View Article and Find Full Text PDF

We describe the first reported case of granulomatosis polyangiitis (GPA)-associated sclerokeratitis in a patient with treated ocular adnexal lymphoma (OAL). The patient presented with pain and decreased vision in the left eye over several weeks. Past medical history was significant for recent bilateral relapsing OAL that was treated successfully with radiotherapy.

View Article and Find Full Text PDF

Scleritis as the harbinger of Granulomatosis with polyangiitis.

Ann Med Surg (Lond)

December 2022

Department of Internal Medicine, Tribhuvan University Teaching Hospital, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.

Introduction: Ocular and orbital involvement in Granulomatosis with polyangiitis (GPA) is common. GPA can lead to life and sight threatening complications due to necrosis and tissue melting.

Cases: We report four cases presenting with ocular pain and redness for varied durations.

View Article and Find Full Text PDF
Article Synopsis
  • The study reports two cases of anterior scleritis occurring in patients who had recently recovered from COVID-19, highlighting a potential complication post-infection.* -
  • The first patient, a 67-year-old woman, required a combination of immunosuppressive treatments after initial therapies failed, while the second patient, a 33-year-old man, showed rapid improvement with corticosteroids.* -
  • The findings suggest that anterior scleritis can develop after COVID-19, and it's important for ophthalmologists to consider this diagnosis in patients experiencing ocular symptoms during recovery.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!